• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Controversies in Modern Eye Care 2023: Living with an untreatable eye disease


Tina Mac Donald, OD, shares highlights from her presentation on living with an untreatable eye disease, which she presented during the 2023 Controversies in Modern Eye Care meeting.

Tina Mac Donald, OD, shares what she hopes attendees took away from her discussion on living with an untreatable eye disease, which she co-presented during the 17th annual Controversies in Modern Eye Care symposium at the Skirball Cultural Center in Los Angeles, California.

This transcript has been edited for clarity.

Tina Mac Donald, OD:

Hi, my name is Tina Mac Donald, I was one of the presenters today at this fabulous conference [and] I work for Western University of Health Sciences College of Optometry.

My presentation today was on living with an untreatable eye disease—specifically macular degeneration. I hope reviewing the prevalence and incidence of this devastating condition was helpful for the attendees, and I hope I gave them takeaways regarding simple things like improved lighting, filters, and some magnification to help those with better acuities. And I hope they learned about amazing technology including AI, VR, and augmented reality to help those return to a more independent state in the lives.

Related Videos
Thomas V. Johnson, MD, PhD, of Wilmer Eye Institute discusses his EyeCon 2023 presentation
Mila Ioussifova, OD, FAAO
Jacob R. Lang, OD, FAAO
Jeffrey J. Walline, OD, PhD
Tracy Doll, OD, FAAO
Shalu Pal, BSc, OD, FAAO
Nate Lighthizer, OD, speaks on lasers in optometry at AAOpt 2023
© 2023 MJH Life Sciences

All rights reserved.